Pentoxifylline for alcoholic hepatitis.

ABSTRACT:

Background

Alcoholic hepatitis is a life-threatening disease, with an average mortality of approximately 40%. There is no widely accepted, effective treatment for alcoholic hepatitis. Pentoxifylline is used to treat alcoholic hepatitis, but there has been no systematic review to assess its effects.

Objectives

To assess the benefits and harms of pentoxifylline in alcoholic hepatitis.

Search strategy

The Cochrane Hepato-Biliary Group Controlled Trials Register, The Cochrane Central Register of Controlled Trials (CENTRAL) in The Cochrane Library, MEDLINE, EMBASE, Science Citation Index Expanded, LILACS, clinicaltrials.gov, and full text searches were conducted until August 2009. Manufacturers and authors were contacted.

Selection criteria

All randomised clinical t

SUBMITTER: Whitfield K 

PROVIDER: S-EPMC6769169 | biostudies-literature | 2009 Oct

REPOSITORIES: biostudies-literature